SCHEMBL13428191

SCHEMBL13428191

c1ccc(-c2ccc(-c3c4ccc(N5c6ccccc6CCc6ccccc65)cc4c(-c4cccc5ccccc45)c4ccc(N5c6ccccc6CCc6ccccc65)cc34)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
LMNA P02545 2/20 0.33
CYP3A4 P08684 1/20 0.33
HTT P42858 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
TNF P01375 1/20 0.33
RECQL P46063 1/20 0.32
MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13008867 0.94 PDE6D (0.34) PDE6DPOLBKDM4EALDH1A1HPGD
SCHEMBL13008826 0.94 PDE6D (0.34) PDE6DPOLBKDM4EALDH1A1HPGD
SCHEMBL13428193 0.93 PDE6D (0.33) PDE6DCA12CA1CA2CA9
SCHEMBL13428147 0.93 PDE6D (0.36) PDE6DCA12CA1CA2CA9
SCHEMBL13009129 0.93 CTDSP1 (0.35) PDE6DCA12CA1CA2CA9
SCHEMBL13428185 0.93 HDAC8 (0.35) PDE6DCA12CA1CA2CA9
SCHEMBL13009166 0.93 POLB (0.38) POLBKDM4EALDH1A1HPGDCYP1A2
SCHEMBL13428182 0.92 POLB (0.33) PDE6DCA12CA1CA2CA9
SCHEMBL13428173 0.92 PDE6D (0.38) PDE6DCA12CA1CA2CA9
SCHEMBL13428125 0.91 HDAC8 (0.36) PDE6DCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PDE6D 3559/4885CA12 3043/4885CA1 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.